Bae Si Hyun, Jang Jeong Won, Kim Min Soo, Oh Hyun Jong, Choi Jong Young, Han Nam Ik, Yoon Seung Kew, Han Joon Yeol, Oh Eun Jee, Kim Dong Gu
Department of Internal Medicine, Kangnam St. Marys Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
Korean J Gastroenterol. 2005 May;45(5):369-73.
Liver transplantation is the only curative therapy for patients with end-stage liver disease. The high success rate and the increasing demand for the transplantation sometimes calls for ABO-compatible but nonidentical blood group orthotopic liver transplantation (OLT), which affords the opportunity to the production of antibody to red blood cells. Hemolytic anemia usually occurs 1 to 2 weeks after transplantation. Although mild in most patients, it can be life-threatening. Until now, a few cases showing hemolytic anemia due to donor ABO antibody formation after ABO-nonidentical OLT have been reported. In the reported cases of hemolytic anemia, most ABO-nonidentical OLT cases were O-to-A, but few reports are available on this subject with O-to-B ABO-nonidentical OLT. Herein, we report the experience with hemolysis after ABO-nonidentical OLT in a group O donor into a group B recipient and the successful treatment with transfusion of washed group O red blood cells and 60 mg dose of prednisolone for 3 days.
肝移植是终末期肝病患者唯一的治愈性疗法。移植的高成功率以及对移植需求的不断增加,有时需要进行ABO血型相容但不相同的原位肝移植(OLT),这为产生针对红细胞的抗体创造了机会。溶血性贫血通常在移植后1至2周发生。虽然大多数患者症状较轻,但也可能危及生命。到目前为止,已有少数关于ABO血型不相容的OLT术后因供体ABO抗体形成导致溶血性贫血的病例报道。在已报道的溶血性贫血病例中,大多数ABO血型不相容的OLT病例是O型供体到A型受体,但关于O型供体到B型受体的ABO血型不相容OLT的相关报道较少。在此,我们报告了1例O型供体到B型受体的ABO血型不相容OLT术后溶血的经验,以及通过输注洗涤后的O型红细胞和60毫克剂量的泼尼松龙治疗3天获得成功的案例。